Sepax Technologies - About the company
Sepax Technologies is a series D company based in Newark (United States), founded in 2002. It operates as a Products and services for biomolecular separation. Sepax Technologies has raised $109M in funding from Fosun and China Life Insurance. The company has 100 active competitors, including 10 funded and 13 that have exited. Its top competitors include companies like Knauer, Restek and Tosoh Bioscience.
Company Details
Sepax Technologies develops and provides solutions, in the form of products and services, for chromatographic biomolecular separation. The company has a growing range of products and technologies in the areas of particle synthesis, surface modification, LC column packing, bulk media production, and purification process development, and covers all major modalities of chromatographic separation including size exclusion, ion exchange, hydrophobic interaction, ion exclusion, UHPLC, reversed phase, mixed-mode phase, HILIC, among others. The company's services include analytical chromatography, prep purification, custom resin and custom surface coatings.
- Website
- sepax-tech.com
- Email ID
- *****@sepax-tech.com
- Phone Number
- +1 **********
- Registered Address
- Newark, Delaware
Key Metrics
Founded Year
2002
Location
Newark, United States
Stage
Series D
Total Funding
$109M in 3 rounds
Latest Funding Round
Ranked
1st among 100 active competitors
Employee Count
90 as on Aug 31, 2026
Legal entities associated with Sepax Technologies
Sepax Technologies is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
SEPAX TECHNOLOGIES, INC CIN: 550787999 , United States, Active | Dec 26, 999 | - | 58 (As on Dec 31, 2024) | - |
Sign up to download Sepax Technologies' company profile
Sepax Technologies's funding and investors
Sepax Technologies has raised a total funding of $109M over 3 rounds. Its first funding round was on Jun 13, 2018. Its latest funding round was a Series D round on Nov 15, 2021 for $*****. 6 investors participated in its latest round. Sepax Technologies has 8 institutional investors.
Here is the list of recent funding rounds of Sepax Technologies:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 15, 2021 | 4069609 | Series D | 5576125 | 2675699 | 1874759 | 6461298 |
Mar 10, 2021 | 1403280 | Series C | 9413355 | 2640100 | 6032132 | 8746616 |
Jun 13, 2018 | 5457851 | Series A | 7943982 | 8032383 | 7607054 | 2279323 |
View details of Sepax Technologies's funding rounds and investors
Sepax Technologies' founders and board of directors
Founder? Claim ProfileSepax Technologies' employee count trend
Sepax Technologies has 90 employees as of Aug 26. Here is Sepax Technologies's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Sepax Technologies's Competitors and alternates
Top competitors of Sepax Technologies include Knauer, Restek and Tosoh Bioscience. Here is the list of Top 10 competitors of Sepax Technologies, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Sepax Technologies 2002, Newark (United States), Series D | Products and services for biomolecular separation | $109M | 54/100 | |
2nd | Provides liquid chromatography solutions | - | 45/100 | ||
3rd | Restek 1985, Bellefonte (United States), Unfunded | Developer and manufacturer of GC and LC columns, standards, accessories and sample prep materials | - | - | 44/100 |
4th | Tosoh Bioscience 1935, Tokyo (Japan), Unfunded | Biomolecular separation instruments, and clinical analyzers | - | - | 44/100 |
5th | Semba Biosciences 2005, Madison (United States), Acquired | Provider of systems for molecular separation based on simulated moving bed chromatography (SMBC) | $5.85M | 43/100 | |
6th | SCION Instruments 2014, Livingston (United Kingdom), Unfunded | Gas Chromatography Solutions | - | - | 42/100 |
7th | ChromaTan 2009, State College (United States), Series A | Novel continuous counter-current tangential chromatography-based separation technology | $5.32M | 41/100 | |
8th | Upfront Chromatography 1992, Copenhagen (Denmark), Series B | Provides chromatography technology for protein separation processes | $32.3M | 41/100 | |
9th | Prometic Bioseparations 2015, Cambridge (United Kingdom), Acquired | Provider of downstream processing solutions focused on affinity chromatography | - | - | 40/100 |
10th | Indigo BioAutomation 2004, Indianapolis (United States), Series B | Automated data analysis, management and integration solutions | $12.3M | 40/100 |
Looking for more details on Sepax Technologies's competitors? Click here to see the top ones
Sepax Technologies's Investments and acquisitions
Sepax Technologies has made no investments or acquisitions yet.
Reports related to Sepax Technologies
Here is the latest report on Sepax Technologies's sector:
News related to Sepax Technologies
Media has covered Sepax Technologies for 1 event in last 1 year.
•
MoleculeMind Raises Over $100 Million in Series A FinancingTMTpost•Jun 17, 2026•Cathay Biotech, Molecular Heart, Oriental Fortune Capital, Blue Bridge Capital and 4 others
•
Are you a Founder ?
FAQs about Sepax Technologies
Explore our recently published companies
- Solar - Indore based, 1994 founded, Unfunded company
- Bina Punjani - India based, 2011 founded, Unfunded company
- Aviator - India based, Unfunded company
- Admit Beacon - India based, 2021 founded, Unfunded company
- Origin Itfs - Chennai based, 1993 founded, Unfunded company
- 1Win - India based, 2026 founded, Unfunded company